PRL and breast carcinoma: The second and larger study of 2,036 postmenopausal women who attended the Norwegian Breast Cancer Screening Program reported a significant interaction between SNP rs10946545 located 1.4kb 3′ of PRL and current use of estrogen-progesterone therapy for percent mammographic density (Pint = 0.0008) [28].